Clinical trial
Assessment of the Effect of Tegaserod (2 mg Tid and 6 mg Tid) on Dyspeptic…
NCT00142974 · Novartis, Industry · Terminated
Key facts
| NCT number | NCT00142974 |
|---|---|
| Title | Assessment of the Effect of Tegaserod (2 mg Tid and 6 mg Tid) on Dyspeptic Symptoms in Diabetic Patients With Symptoms of Diabetic Gastropathy |
| Official title | Assessment of the Effect of Tegaserod (2 mg Tid and 6 mg Tid) on Dyspeptic Symptoms in Diabetic Patients With Symptoms of Diabetic Gastropathy |
| Lead sponsor | Novartis, Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Diabetic Gastropathy |
| Intervention type | Drug |
| Interventions | Tegaserod |
| Enrollment | 120 |
| Start date | May 1, 2004 |
| Primary completion | Apr 1, 2005 |
| Completion | Apr 1, 2005 |
| First posted | Sep 2, 2005 |
| Last update posted | Apr 20, 2012 |
| Countries | Switzerland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: